                         SEQUENCE LISTING

<110>  F. Hoffmann-La Roche AG, Basel (CH)
       Roche Diagnostics GmbH, Mannheim (DE)
 
<120>  SYSTEM AND METHOD FOR GENERATION AND USE OF COMPACT CLONALLY 
       AMPLIFIED PRODUCTS

<130>  30889 WO

<150>  US 61/601,824
<151>  2012-02-22

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ultra High-throughput Test Fragment 2 (UHTF2)

<400>  1
tacgcaagct aagccatatc cttattaaag cttttttgaa agttaatcgt                  50


<210>  2
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ultra High-throughput Test Fragment 79 (UHTF 79)

<400>  2
atcgttcccc cgcggcgccg ggcccggcac taggcggggg cctaggtgca                  50


<210>  3
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ultra High-throughput Test Fragment 90 (UHTF 90)

<400>  3
acgtaaaaac ttaaaactca aactcaacgc accagcctat gcgcctggtc                  50


<210>  4
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ultra High-throughput Test Fragment 100 (UHTF 100)

<400>  4
gcatccgagc cctatcccct atccccctat tctcttgagg agagtcaacc                  50


<210>  5
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ultra High-throughput Test Fragment 120 (UHTF 120)

<400>  5
gtacggatag ggatagggga tcgggggata ggcttaactc atttctctac                  50


<210>  6
<211>  50
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Ultra High-throughput Test Fragment 150 (UHTF 150)

<400>  6
cgtattttta cgttttagat ttagattgcg ttataaccca tactaggggg                  50


